Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
2853 Ergebnisse für "acute" unter Roche Glycart AG
Acute Ischemic Stroke
... responsibility for access to or use of this website, nor for any content therein. Acute Ischemic Stroke ... Acute Ischemic Stroke ... https://medically.roche.com/hu/en/neuroscience/diseases/ acute-ischemic-stroke.html ... Acute Ischemic Stroke ...
Acute Myeloid Leukemia
... responsibility for access to or use of this website, nor for any content therein. Acute Myeloid Leukemia ... Acute Myeloid Leukemia ... https://medically.roche.com/global/en/haematology/diseases/ acute-myeloid-leukemia.html ... Acute Myeloid Leukemia ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1771 Ergebnisse für "acute" unter Somagenetix
FG: Hemodynamic Mechanisms of Acute Kidney Injury
... FG: Hemodynamic Mechanisms of Acute Kidney Injury U N I V E R S I T Ä T S M E D I Z I N B E R L I N ... FG: Hemodynamic Mechanisms of Acute Kidney Injury ... FG: Hemodynamic Mechanisms of Acute Kidney Injury U N I V E R S I T Ä T S M E D I Z I N B E R L I N ... FG: Hemodynamic Mechanisms of Acute Kidney Injury ...
Acute coronary and cerebrovascular syndrome - Zurich Open Repositor...
... Acute coronary and cerebrovascular syndrome Copy Communities & Collections: Publisher DOI: OAI 2.0 ... Acute coronary and cerebrovascular syndrome - Zurich Open Repository and Archive ... Acute coronary and cerebrovascular syndrome - Zurich Open Repository and Archive Header ... Acute coronary and cerebrovascular syndrome - Zurich Open Repository and Archive ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
547 Ergebnisse für "acute" unter University of Zurich
The Burden of Acute and Long-Term Side Effects
... , Psychotherapy and Psychosomatics Psychiatric Hospital, University of Zurich The Burden of Acute and Long-Term ... risks associated with their use. These risks are primarily acute and chronic neurological ... The Burden of Acute and Long-Term Side Effects ... The Burden of Acute and Long-Term Side Effects Research Group 'Psychiatric Genetics', Head: Prof ... The Burden of Acute and Long-Term Side Effects ...
The Burden of Acute and Long-Term Side Effects
... Psychiatric Hospital, University of Zurich The Burden of Acute and Long-Term Side Effects Significant Risks In ... their use. These risks are primarily acute and chronic neurological adverse effects, such as ... The Burden of Acute and Long-Term Side Effects ... The Burden of Acute and Long-Term Side Effects Professor Dr. med. Christian Scharfetter Department ... The Burden of Acute and Long-Term Side Effects ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
70 Ergebnisse für "acute" unter Blutspende SRK Zürich
Measures to prevent transfusionrelated acute lung injury (TRALI)
... Measures to prevent transfusionrelated acute lung injury (TRALI) Measures to prevent transfusion ... -related acute lung injury (TRALI) H. W. Reesink, J. Lee, A. Keller, P. Dennington, J. Pink, R. Holdsworth ... Measures to prevent transfusionrelated acute lung injury (TRALI) ... Measures to prevent transfusionrelated acute lung injury (TRALI) Measures to prevent transfusion ... Measures to prevent transfusionrelated acute lung injury (TRALI) ...
Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Don...
... Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020 Citation ... , B.M. Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020. Viruses 2024 ... Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020 ... Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020 Citation ... Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020 ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
264 Ergebnisse für "acute" unter ETH Entrepreneurship
Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive...
... Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in ... Rats Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in ... Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in ... Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in ... Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in ...
The brain’s hemodynamic response function rapidly changes under acu...
... The brain’s hemodynamic response function rapidly changes under acute psychosocial stress in ... rapidly changes under acute psychosocial stress in association with genetic and endocrine stress response ... The brain’s hemodynamic response function rapidly changes under acute psychosocial stress in ... The brain’s hemodynamic response function rapidly changes under acute psychosocial stress in ... The brain’s hemodynamic response function rapidly changes under acute psychosocial stress in ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
1661 Ergebnisse für "acute" unter University Hospital Zurich, Research and Education Office
Slide S I 10
... acute ulcero-phlegmonous appendicitis ICD-10: K35.9 S I 10 weitere Informationen auf ... HiPaKu - Entzündliche Infiltration des Mesenteriolum 10-year-old boy with acute right lower quadrant ... Slide S I 10 Akute ulzero-phlegmonöse Appendizitis acute ulcero-phlegmonous appendicitis HE acute ... Mesenteriolum 10-year-old boy with acute right lower quadrant abdominal pain, rebound tenderness and fever ...
Slide A IV 2
... Akute ulzero-phlegmonöse Appendizitis acute ulcero-phlegmonous appendicitis HE acute ulcero ... underwent appendectomy because of acute pain in the right lower quadrant. - Fibrotic obliteration of the tip ... Slide A IV 2 Akute ulzero-phlegmonöse Appendizitis acute ulcero-phlegmonous appendicitis HE acute ... appendectomy because of acute pain in the right lower quadrant. - Fibrotic obliteration of the tip of the ...
GlycoEra AG
8820 Wädenswil, Einsiedlerstrasse 34
+41 44 733 85 75
info@glycoera.com
GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges! The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.
GlycoEra AG
Einsiedlerstrasse 34
8820 Wädenswil
1 Ergebnisse für "acute" unter GlycoEra AG
Comments on:
... https://glycoera.com/improved-detection-of- acute-lyme-disease/feed/ ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
11 Ergebnisse für "acute" unter InSphero AG
Insphero
... cardiac microtissues as an ideal in vitro model for the study of acute and chronic toxicity. ... cardiac microtissues as an ideal in vitro model for the study of acute and chronic toxicity. More details ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
4 Ergebnisse für "acute" unter Neurimmune Therapeutics AG
Neurimmune - Biogen
... , neurocognitive disorders, acute neurology and pain. ... , neurocognitive disorders, acute neurology and pain. Aducanumab results showed removal of amyloid plaques in ...
Neurimmune - 01.05.2018: Biogen and Neurimmune Announce Option Exer...
... disorders, pain, ophthalmology, neuropsychiatry, and acute neurology. Biogen also manufactures and ... disorders, pain, ophthalmology, neuropsychiatry, and acute neurology. Biogen also manufactures and ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
20 Ergebnisse für "acute" unter CSL Vifor
CSL Annual Report 2023 – Page 13
... ® (Ferroportin inhibitor) Sickle Cell Disease CSL301 (α2 Anti-Plasmin mAb) Sub- acute Pulmonary Embolism* CSL889 ... Cardiovascular and Metabolic Clinical Registration Post-Launch CSL112 Apolipoprotein A-I (human) Acute Myocardial ... - acute Pulmonary Embolism* CSL889 (Hemopexin) Sickle Cell Disease Respiratory Clinical Registration Post ... CSL112 Apolipoprotein A-I (human) Acute Myocardial Infarction Clazakizumab (Anti-IL-6 mAb) End Stage ...
Current Clinical Trials | CSL
... Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP ... Corticosteroids Compared with Corticosteroids Alone as First Line Therapy for Patients with High-risk Acute GVHD ... Sickle Cell Disease Recruiting Traumatic Injury and Acute Major Bleeding BE1116_3006 Evaluation of ... BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ...
